Stock GSTh GOLDEN SUN CAPITAL INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Golden Sun Capital Inc Toronto S.E.

Equities

GSTh

CA38123A1093

End-of-day quote Toronto S.E.
Other stock markets
- - Intraday chart for Golden Sun Capital Inc
Jun. 11 Voyageur Pharmaceuticals Ltd. and Rain Cage Carbon Inc. Announce Follow Up on the First Commercial Creation of V@C60 Endohedral Fullerene CI
May. 28 Voyageur Pharmaceuticals Ltd Secures USD 1.9 Million Sales Contract for SmoothXTM 2% Barium Contrast CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Voyageur Pharmaceuticals and Rain Cage Carbon Partner to Develop Advanced Radiology Contrast Agents
AQ
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development
AQ
Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America
AQ
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast
AQ
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors
AQ
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
AQ
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
AQ
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement
AQ
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement
AQ
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
AQ
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule
AQ
Voyageur Pharmaceuticals takes major step forward announcing international expansion
AQ
Voyageur Pharmaceuticals Initiates International Expansion
AQ
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium
AQ
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media
AQ
Voyageur Pharmaceuticals Ltd. Announces Filing of Interim Financial Statements, Director Changes and Grant of Stock Options
AQ
Voyageur Pharmaceuticals Ltd. Announces DSU Grants
AQ
Voyageur Pharmaceuticals Publishes White Paper, SmoothX: A Promising New Positive Oral Contrast Agent That Enhances Patient Satisfaction and Diagnostic Excellence in CT Imaging
AQ
Voyageur Pharmaceuticals shares successful environmental assessment for minerals subsidiary
AQ
Voyageur Pharmaceuticals with a "big market to go for"
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VM Stock
  4. GSTh Stock
  5. News Golden Sun Capital Inc
  6. Press Releases